Innospec Inc.

Valuation Analysis

About the Company

Innospec Inc. en bref

Innospec Inc. (IOSP) is currently trading at 72,20 € with a market capitalization of 1,8 Md €. The trailing P/E ratio stands at 18.06x, with a forward P/E of 13.54x. The 52-week range spans from 57,17 € to 80,41 €; the current price is 10.2% below the yearly high. Year-over-year revenue growth stands at +2.8%. The net profit margin stands at 6.38%.

💰 Dividende

Innospec Inc. currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

3 analystes évaluent Innospec Inc. (IOSP) au consensus : Achat Fort. L'objectif de cours moyen est de 86,68 €, soit un potentiel de +20.07% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 81,16 € à 91,63 €.

Innospec Inc. : la thèse d'investissement en détail

Innospec Inc. (IOSP) operates in the Basic Materials — specifically Specialty Chemicals — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Wall Street consensus sits at Strong Buy with an average price target implying roughly 20.07% upside from current levels — analyst sentiment is firmly constructive.

Le scénario baissier

Revenue growth has slowed to just 2.8%, which is below nominal GDP — the business is no longer outgrowing the broader economy.

Valorisation en contexte

With a PEG ratio of 0.66, the price-to-earnings multiple is actually below the company's growth rate — classic value-meets-growth territory that Peter Lynch would have called a 'GARP' opportunity. The EV/EBITDA multiple of 9.78x is below the historical equity-market average — strategic acquirers would find the cash-flow profile attractive at this level.

À surveiller

• The forward P/E of 13.54x is meaningfully below the trailing 18.06x — analysts expect earnings to step up; the next earnings release is the test.
• The analyst consensus price target implies 20.07% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Profil de risque

The data points to relatively defensive market behavior.

Trading Data

Related Stocks in the Same Sector

Where can I buy Innospec Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.